BECTON DICKINSON & CO
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 9/30/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 19,181 | 43.0 |
| Stockholders' equity | 25,390 | 57.0 |
| Total capitalization | 44,571 | 100.0 |
272,386,800 shares outstanding at 30 June 2026 (cover page of the 10-Q filed 6 August 2026).
LONG-TERM DEBT 9/30/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, noncurrent | 17,621 |
| Current maturities | 1,560 |
CAPITAL STOCK 9/30/25
| Common shares authorized | 640,000,000 |
| Common shares issued | 370,594,401 |
| Treasury shares | 85,192,233 |
| Par or stated value per share ($) | 1 |
| Outstanding at 6/30/26 | 272,386,800 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | 4.16 | 71.5 |
| 2024 | 3.80 | 64.8 |
| 2023 | 3.64 | 73.7 |
| 2022 | 3.48 | 59.2 |
| 2021 | 3.32 | 48.5 |
HISTORY AND BUSINESS
HISTORY: Incorporated in New Jersey.
BUSINESS: Classified by the SEC under Standard Industrial Classification 3841, Surgical & Medical Instruments & Apparatus. Large accelerated filer. Principal executive office: One Becton Dr, Franklin Lakes, NJ 07417-1880. Fiscal year ends September 30. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 9/30/25 | 9/30/24 | 9/30/23 |
|---|---|---|---|
| Revenues | 21,840 | 20,178 | 19,372 |
| Cost of revenues | 11,915 | 11,053 | 11,202 |
| Research and development | 1,265 | 1,190 | 1,237 |
| Selling, general and administrative | 5,278 | 4,857 | 4,719 |
| Depreciation and amortization | 2,462 | 2,286 | 2,288 |
| Operating income | 2,579 | 2,397 | 2,111 |
| Interest expense | 613 | 528 | 452 |
| Income before income taxes | 1,881 | 2,005 | 1,662 |
| Income taxes | 203 | 300 | 132 |
| Net income | 1,678 | 1,705 | 1,484 |
| Earned per share, diluted ($) | 5.82 | 5.86 | 4.94 |
| Dividends per share ($) | 4.16 | 3.80 | 3.64 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 9/30/25 | 9/30/24 |
|---|---|---|
| Cash and equivalents | 641 | 1,717 |
| Receivables, net | 2,994 | 3,033 |
| Inventories | 3,894 | 3,843 |
| Total current assets | 9,255 | 10,468 |
| Property, plant and equipment, net | 6,997 | 6,821 |
| Goodwill | 26,612 | 26,465 |
| Total assets | 55,325 | 57,286 |
| Total current liabilities | 8,313 | 8,956 |
| Long-term debt | 17,621 | 17,940 |
| Stockholders' equity | 25,390 | 25,890 |
| Total liabilities and equity | 55,325 | 57,286 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9/30/25 | 21,840 | 2,579 | 1,678 | 7.7 | 5.82 | 4.16 | 3,430 | 760 | 2,670 | 55,325 | 29,935d | 19,181 | 25,390 | 6.6 | 0.76 |
| 9/30/24 | 20,178 | 2,397 | 1,705 | 8.4 | 5.86 | 3.80 | 3,844 | 725 | 3,119 | 57,286 | 31,396d | 20,110 | 25,890 | 6.6 | 0.78 |
| 9/30/23 | 19,372 | 2,111 | 1,484 | 7.7 | 4.94 | 3.64 | 2,990 | 874 | 2,116 | 52,780 | 26,984d | 15,879 | 25,796 | 5.8 | 0.62 |
| 9/30/22 | 18,870 | 2,282 | 1,779 | 9.4 | 5.88 | 3.48 | 2,471 | 973 | 1,498 | 52,934 | 27,652d | 16,065 | 25,282 | 7.0 | 0.64 |
| 9/30/21 | 19,131 | 2,250 | 2,092 | 10.9 | 6.85 | 3.32 | 4,647 | 1,194 | 3,453 | 53,866 | 30,189d | 17,610 | 23,677 | 8.8 | 0.74 |
| 9/30/20 | 16,074 | 912 | 874 | 5.4 | 2.71 | 3.16 | 3,539 | 769 | 2,770 | 54,012 | 30,247d | 17,931 | 23,765 | 3.7 | 0.75 |
| 9/30/19 | 17,290 | 1,760 | 1,233 | 7.1 | 3.94 | 3.08 | 3,330 | 957 | 2,373 | 51,765 | 30,684d | 19,390 | 21,081 | 5.8 | 0.92 |
| 9/30/18 | 15,983 | 1,509 | 311 | 1.9 | 0.60 | 3.00 | 2,865 | 895 | 1,970 | 53,904 | 32,910d | 21,495 | 20,994 | 1.5 | 1.02 |
| 9/30/17 | 12,093 | 1,522 | 1,100 | 9.1 | 4.60 | 2.92 | 2,550 | 727 | 1,823 | 37,734 | 24,786d | 18,870 | 12,948 | 8.5 | 1.46 |
| 9/30/16 | 12,483 | 1,430 | 976 | 7.8 | 4.49 | 2.64 | 2,559 | 693 | 1,866 | 25,586 | 17,953d | 11,551 | 7,633 | 12.8 | 1.51 |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
BECTON DICKINSON & CO
CIK 10795 · EIN 22-0760120
PRINCIPAL OFFICE:
One Becton Dr, Franklin Lakes, NJ 07417-1880
Tel.: 2018476800
INCORPORATED:
New Jersey
INDUSTRY (SEC SIC CODE):
3841 · Surgical & Medical Instruments & Apparatus
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 9/30/25, filed 25 November 2025
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 11/25/25) · 10-K FY2024 (filed 11/27/24) · 10-K FY2023 (filed 11/21/23) · 10-K FY2022 (filed 11/22/22) · 10-K FY2021 (filed 11/24/21) · 10-K FY2020 (filed 11/25/20) · 10-K FY2019 (filed 11/27/19) · 10-K FY2018 (filed 11/21/18). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.